Search results
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias...
WKBN 27 Youngstown· 7 hours agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance· 17 hours agoThose results won it a standing ovation from attendees at the recent American Society of Clinical ...
West Cancer Center & Research Institute specialists featured at prestigious oncology event - Memphis...
The Business Journals· 1 day agoSix of West Cancer Center & Research Institute’s oncology specialists presented key research on very...
Molecular Characterization Initiative for Childhood Cancers
National Cancer Institute· 3 hours agoWhat is molecular characterization? Looking at cancer at a molecular level helps to provide a precise diagnosis and tell doctors more about what might be causing or driving an individual cancer ...
Kura Oncology, Inc. (NASDAQ:KURA) Given Average Rating of “Moderate Buy” by Analysts
ETF DAILY NEWS· 1 day agoKura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat ...
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput...
Morningstar· 12 hours agoVenlo, the Netherlands, and Redwood City, California, June 13, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the release of a new version of its ...
Pyxis Oncology adds biopharma veteran to board By Investing.com
Investing.com· 4 days agoPyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage biotechnology company developing therapies for...
J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing...
Benzinga· 4 days agoIn addition, the first instance of brain tumor activity was recorded in Cohort...
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as...
Yucaipa News Mirror· 1 day agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of
NHS boss calls for broad range of clinical research
Clinical Trials Arena via Yahoo Finance· 2 days agoAustin also spoke about how NHS England is trying to engage patients in clinical research, including the utilisation of the NHS app that includes a...